Article Tools/Herramientas de artículos
+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña






Scientific News Salesforce, Thermo Fisher Scientific, Crowdstrike And More Cnbc S Final Trades

Search Related Content

Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Salesforce, Thermo Fisher Scientific, Crowdstrike And More Cnbc S Final Trades is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.
Search RobinsPost News & Noticias


Scientific News Salesforce, Thermo Fisher Scientific, Crowdstrike And More Cnbc S Final Trades | RobinsPost News & Noticias

Thermo Fisher Expands Biopharma Offerings With $9B Deal for Clinical Trial Software Firm Clario


Private equity-backed Clario brings to Thermo Fisher Scientific software that collects, manages, and analyzes clinical trial endpoint data. Read More

Thermo Fisher to acquire clinical trial data firm Clario for $8.9B


The purchase is expected to complement Thermo’s clinical research services, as companies are conducting more trials. Read More

Thermo Fisher's Upbeat Earnings Suggest Worst Is Over For Scientific Tools Sector, Analyst Says


Thermo Fisher Scientific Inc. (NYSE:TMO) on Wednesday reported third-quarter 2025 adjusted earnings of $5.79 per share, beating the street view of $5.49. • TMO stock is showing upward bias. Get the ... Read More

Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion


Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion in cash and future payments, strengthening the life science firm's presence in digital ... Read More

Thermo Fisher Scientific to Acquire Clario to Provide Deeper Clinical Insights


Acquisition is expected to strengthens Thermo Fisher’s position in delivering clinical information to pharma and biotech customers. Read More

Thermo Fisher to buy Clario for ~$8.9B plus earnouts


Please provide the article or its content so I can generate an SEO-friendly meta description according to your instructions. Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus